Literature DB >> 29485913

An update on radiation therapy in head and neck cancers.

Rosario Mazzola1, Alba Fiorentino1, Francesco Ricchetti1, Fabiana Gregucci1, Stefanie Corradini2, Filippo Alongi1,3.   

Abstract

INTRODUCTION: Technological and technical improvements allowed for significant advances in the field of radiation therapy (RT) of head and neck cancer (HNC). Several organ-sparing strategies have been investigated with the objective to decrease acute and long-term adverse effects and, subsequently, to assure a better quality of life in patients affected by HNC. In this context, intensity modulated irradiation and the use of multimodality-imaging could help clinicians to obtain a rapid dose fall off towards surrounding healthy tissues and a better delineation of targets volumes and organs at risk. Areas covered: A literature review was performed with the aim to offer an update on radiation therapy in HNC. Expert commentary: During these last years, radiation oncologists have observed a continuous changing regarding radiation treatment for HNC. The adoption of intensity-modulated RT (IMRT) and the use of multimodality-imaging for tumor volume definition and organs at risk or delineation have improved the clinical outcomes of HNC patients. In the future, a better integration of functional imaging for target volume delineation as well as adaptive delivery strategies will allow to further personalize radiation oncology in HNC. Furthermore, the latest breakthrough technologies, such as magnetic resonance imaging (MRI)-linacs and heavy particles technologies have a great potential to improve treatment-related quality of life in HNC. Future studies are needed to demonstrate the clinical advantages of these new RT technologies in HNC.

Entities:  

Keywords:  Head and neck cancers; IMRT; chemotherapy; radiotherapy; update

Mesh:

Year:  2018        PMID: 29485913     DOI: 10.1080/14737140.2018.1446832

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  5 in total

1.  Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis.

Authors:  Lei Wang; Zheng Wu; Dehuan Xie; Shaowen Lv; Liangping Xia; Yong Su
Journal:  Radiat Oncol       Date:  2020-07-02       Impact factor: 3.481

2.  A comparison of clinical outcomes between simultaneous integrated boost (SIB) versus sequential boost (SEQ) intensity modulated radiation therapy (IMRT) for head and neck cancer: A meta-analysis.

Authors:  Li Jiang; Yong Zhang; Zhendong Yang; Feifei Liang; Jiangtao Wu; Rensheng Wang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.889

Review 3.  Nimotuzumab for Patients With Inoperable Cancer of the Head and Neck.

Authors:  Tania Crombet Ramos; Braulio Mestre Fernández; Zaima Mazorra Herrera; Normando E Iznaga Escobar
Journal:  Front Oncol       Date:  2020-05-27       Impact factor: 6.244

4.  Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 "QUAD shot" regimen for incurable head and neck cancer.

Authors:  Ryo Toya; Tetsuo Saito; Kohsei Yamaguchi; Tomohiko Matsuyama; Takahiro Watakabe; Tadashi Matsumoto; Ryoji Yoshida; Akiyuki Hirosue; Daizo Murakami; Yorihisa Orita; Hideki Nakayama; Natsuo Oya
Journal:  Radiat Oncol       Date:  2020-05-27       Impact factor: 3.481

5.  Effectiveness and cost-effectiveness analysis of nimotuzumab for the radiotherapy of locoregionally advanced nasopharyngeal carcinoma.

Authors:  Zhaodong Fei; Ting Xu; Mengying Li; Taojun Chen; Li Li; Xiufang Qiu; Chuanben Chen
Journal:  Radiat Oncol       Date:  2020-10-02       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.